GARS1 Gene CMT2D Genetic Test
At DNA Labs UAE, we offer the GARS1 Gene CMT2D Genetic Test to diagnose Charcot-Marie-Tooth disease type 2D (CMT2D), a hereditary neuropathy that affects the peripheral nerves. This test analyzes the DNA sequence of the GARS1 gene to identify any mutations or variations that may be causing the disease.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to the GARS1 Gene CMT2D Genetic Test, it is important to provide the clinical history of the patient who is undergoing the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with GARS1 Gene CMT2D.
Test Details
The GARS1 gene is associated with Charcot-Marie-Tooth disease type 2D (CMT2D), a hereditary neuropathy that affects the peripheral nerves. Our NGS genetic test for CMT2D analyzes the DNA sequence of the GARS1 gene to identify any mutations or variations that may be causing the disease. This test can help diagnose CMT2D and provide information about the genetic risk for family members.
Treatment for CMT2D is supportive and may include physical therapy, occupational therapy, and medications to manage symptoms.
Test Name | GARS1 Gene CMT2D Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GARS1 Gene CMT2D NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GARS1 Gene CMT2D |
Test Details |
The GARS1 gene is associated with Charcot-Marie-Tooth disease type 2D (CMT2D), a hereditary neuropathy that affects the peripheral nerves. The NGS genetic test for CMT2D analyzes the DNA sequence of the GARS1 gene to identify any mutations or variations that may be causing the disease. This test can help diagnose CMT2D and provide information about the genetic risk for family members. Treatment for CMT2D is supportive and may include physical therapy, occupational therapy, and medications to manage symptoms. |